Dr Vivien CHUANG Associate Consultant Infection Control Branch, Centre for Health Protection/ Infectious Disease Control and Training Center,

Similar documents
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

CONTAGIOUS COMMENTS Department of Epidemiology

Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

Infection Control of Emerging Diseases

Antimicrobial Susceptibility Testing: Advanced Course

Carbapenemase-Producing Enterobacteriaceae (CPE)

2015 Antimicrobial Susceptibility Report

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S

Concise Antibiogram Toolkit Background

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Hospital Acquired Infections in the Era of Antimicrobial Resistance

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Dr.Asad A. Khan FRCPC Consultant, Division of Infectious Diseases Tawam Hospital Al Ain, UAE

Antimicrobial Cycling. Donald E Low University of Toronto

RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR

The relevance of Gram-negative pathogens for public health situation in India

2015 Antibiotic Susceptibility Report

Mechanism of antibiotic resistance

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Breaking the Ring. β-lactamases and the Great Arms Race. Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)

Birgit Ross Hospital Hygiene University Hospital Essen Essen, Germany. Should we screen for multiresistant gramnegative Bacteria?

Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from a Tertiary Care Centre, Bengaluru, India

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

Detection of Inducible AmpC β-lactamase-producing Gram-Negative Bacteria in a Teaching Tertiary Care Hospital in North India

Multi-drug resistant microorganisms

INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS

Antimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013

Imagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening

Antimicrobial Resistance and Prescribing

Helen Heffernan. Rosemary Woodhouse

Rise of Resistance: From MRSA to CRE

Public Health Response to Emerging Resistance

C&W Three-Year Cumulative Antibiogram January 2013 December 2015

CARBAPENEM RESISTANT ENTEROBACTERIACEAE (KPC CRE)

Resistant Gram-negative Bacteria

2016 Antibiotic Susceptibility Report

The MALDI-TOF Mass Spectrometer and Diagnostic Bacteriology

Antimicrobial Susceptibility Profile of E. coli Isolates Causing Urosepsis: Single Centre Experience

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

Comparison of in vitro efficacy of ertapenem, imipenem and meropenem by the Enterobacteriaceae strains family

Antimicrobial susceptibility

Prevention, Management, and Reporting of Carbapenem-Resistant Enterobacteriaceae

Infection Prevention and Control Policy

Antibiotic resistance in antibiotic free environment. Vladimir Krcmery Jaroslava Sokolova

Other Enterobacteriaceae

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

What do we know about multidrug resistant bacteria in New Zealand s pet animals?

ESBL Positive E. coli and K. pneumoneae are Emerging as Major Pathogens for Urinary Tract Infection

Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units

Acinetobacter Resistance in Turkish Tertiary Care Hospitals. Zeliha KOCAK TUFAN, MD, Assoc. Prof.

β-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa March 2018

Gram negative bacteraemia

4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:

Two (II) Upon signature

Antimicrobial Resistance Surveillance in the South African Public Sector

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae

Witchcraft for Gram negatives

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Intrinsic, implied and default resistance

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India

Using Web-Based Instruction Modules to Improve Practitioner Knowledge at Yale New Haven Hospital on the Prevention of Antimicrobial Resistance and

Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland,

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

WHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis

ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF ENTEROBACTERIACEAE ISOLATED FROM URINE SAMPLES AT THE KENYATTA NATIONAL HOSPITAL MICROBIOLOGY LABORATORY

EXTENDED-SPECTRUM BETA-LACTAMASES EMERGING GRAM-NEGATIVE ORGANISMS

Multi-drug resistant Acinetobacter (MDRA) Surveillance and Control. Alison Holmes

Infectious Disease: Drug Resistance Pattern in New Mexico

ADC 2016 Report on Bacterial Resistance in Cultures from SEHOS and General Practitioners in Curaçao

Recommendations Regarding Use of Rapid Blood Pathogen Identification Panel Data

Comparison of Susceptibility of Gram Negative Bacilli to Cephalosporins and Ciprofloxacin

Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli"

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

ALARMING RATES OF PREVALENCE OF ESBL PRODUCING E. COLI IN URINARY TRACT INFECTION CASES IN A TERTIARY CARE NEUROSPECIALITY HOSPITAL

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

Antimicrobial Resistance

Acinetobacter Outbreaks: Experience from a Neurosurgery Critical Care Unit. Jumoke Sule Consultant Microbiologist 19 May 2010

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

ANTIMICROBIAL STEWARDSHIP IN LONG TERM CARE FACILITIES

CONTAGIOUS COMMENTS Department of Epidemiology

Antimicrobial Resistance Strains

International Journal of Pharma and Bio Sciences ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI ABSTRACT

Dr. Kevin Katz, MD, MSc, FRCPC Medical Director of IPAC, NYGH IPAC Physician Consultant, PHO

Other Beta - lactam Antibiotics

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

Antimicrobial Resistance: Do we know everything? Dr. Sid Thakur Assistant Professor Swine Health & Production CVM, NCSU

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Transcription:

Dr Vivien CHUANG Associate Consultant Infection Control Branch, Centre for Health Protection/ Infectious Disease Control and Training Center, Hospital Authority

NDM-1, which stands for New Delhi Metallo-beta-lactamase-1 新德里金属酰胺酶 This is a Carbapenemase which neutralizes the activity of carbepenem antibiotics.

Resistance to carbapenems is mediated by mechanisms: 1. loss of outer membrane proteins, and 2. production of carbapenemases that are capable of hydrolyzing the carbapenems. Enterobacteriaceae Family: Escherichieae (E.coli), Edwardsiella, Salmonella, Shigella, Citrobacter, Klebsiella, (K. pneumonia), Enterobacter, Morganella, Proteus, Serratia, Pantoea, Hafnia, Providencia, Yersinia Carbapenem resistant Enterobacteriaceae (CRE) Carbapenemase producing Enterobacteriaceae

Plasmid mediated NDM-1

A 59-year-old male, a Swedish patient of Indian origin Underlying diseases: Type 2 diabetes mellitus, multiple strokes Nov 07, he traveled to India 5 Dec 07, admitted to local hospital with a large gluteal abscess in Ludhiana, Punjab. He transferred to a hospital in New Dehli, he was operated on and where he developed a decubital ulcer Antibiotics given: Augumentin, metronidazole, amikacin, and gatifloxacin (all of them parenterally). Antimicrobiol agent and Chemotherapy 2009; 53(12):5046-54

8 Jan 2008, he was referred to a hospital in Sweden 9 Jan 2008, 1. Urine sample: NDM-1 K. penumoniae which is R to all lactams, but S to Colistin 2. Deep wounds: ESBL-positive E. coli and carbapenemsusceptible Acinetobacter sp. 3. External otitis fluid: An ESBL-positive E. coli 6 Mar 08, the patient was discharged to a nursing home. Antimicrobiol agent and Chemotherapy 2009; 53(12):5046-54

1 Apr 08, 1. Urine sample: an ESBL-producing K.pneumoniae 2. The original carbapenem-resistant K. pneumoniae isolate has never been found in any other cultures of samples from the patient Fecal samples: E. coli NDM-1 NDM-1 K. penumoniae could not be recovered Antimicrobiol agent and Chemotherapy 2009; 53(12):5046-54

1. possible transfer of blandm-1 in vivo either from K. pneumoniae to E. coli or vice versa, but more interestingly, the plasmids carrying blandm-1 in the two species are of different sizes 2. This evidence would suggest that there is rearrangement in vivo which could result from either duplication and insertion, e.g. transposition or rolling circle replication from the smaller plasmid, or deletion from the larger plasmid 3. The plasmid carrying blandm-1 also carries blacmy-4 and the complex class 1 integron carrying several antibiotic resistance-conferring gene 4. It has also shown itself to naturally have a broad host range.

When the plasmid was transferred to E. coli J53, the E. coli strain containing pndm-1 was resistant to all antibiotics except colistin and ciprofloxacin and was shown by blotting and PCR to carry blacmy-4, the ISCR region, and blandm-1

NDM-1 not only is a new subclass of the B1 group of MBLs but also possesses novel amino acids near the active site, suggesting that it has a novel structure NDM-1 possesses relatively high Km and kcat values for both imipenem and meropenem (efficient hydrolysis profile)

www.thelancet.com/infection Published online August 11, 2010 DOI:10.1016/S1473-3099(10)70143-2

Haryana Chennai 47 CRE (24%) of 198 Enterobacteriaceae were identified; OF 47 CRE, 26(55%) were NDM-1, and all were K pneumoniae In 2009, 3521 (4%) Enterobacteriaceae were CRE Of these 141 CRE, 44 (31%) were NDM-1 19 E coli, 14 K pneumoniae, 7 Enterobacter cloacae, 2 Proteus spp, 1 Citrobacter freundii, 1 Klebsiella oxytoca) Infection: community acquired UTI, pneumonia, and BSI Age: mean 36 years (range was 4 66 )

2008: NDM-1isolate was first detected 2008 09: 37 NDM- 1Enterobacteriaceae isolates. These were identified as K pneumoniae (21), E coli (7), Enterobacter spp (5), Citrobacter freundii (2), Morganella morganii (1), and Providencia spp (1) 2009: 32 (44%) of 73 carbapenemase-producing Enterobacteriaceae are NDM-1

Body sites: urine (52%), blood (10%),burn or wound swab (13.8%), sputum (6.9%), central line tip (3%), throat swab (3%), or unknown specimens (10%) Mean age: 60 years (range 1 87) At least 17 (59%) patients had a history of travelling to India or Pakistan within 1 year, and 14 (48%) of them had been admitted to a hospital in these countries

Chennai Haryana UK Clonality Non-clonal Clonal (outbreak potential) Location of blandm-1 gene Plasmid only Plasmid only Plasmid size 50-350 kb 118 kb (54%) or 50 kb (36%). plasmid movement between bacterial isolates Non-clonal Plasmid (chromosome, in situ movement of blandm-1 gene blandm-1 was carried on more than one plasmid 80 - >500kb Evident by many plasmids of identical size in isolates collected from India and the UK

Jan Jun 10, 3 NDM-1 Enterobacteriaceae isolates were identified from 3 U.S. states at the CDC antimicrobial susceptibility laboratory These isolates, which include an E. coli, K. pneumoniae, and E. cloacae, carry blandm-1, which confers resistance to all beta-lactam agents, including aztreonam All three U.S. isolates were from patients who received recent medical care in India MMWR / June 25, 2010 / Vol. 59 / No. 24

A man from Canberra, aged in his mid 50s, had elective plastic surgery in India in Sep 09. Complicated by a hypoxic brain injury, with ICU care for 4 weeks Transferred back to Canberra for ongoing hospital care. CSU on admission in Nov 09 : a heavy growth of multidrug-resistant P. rettgeri and P. aeruginosa. The P. rettgeri R to all b-lactam antibiotics, including meropenem, as well as to all aminoglycosides, ciprofloxacin, tigecycline and colistin. The P. aeruginosa was R to all antipseudomonal antibiotics except for colistin. P. rettgeri had 100% homology with blandm-1 The patient was not given antibiotic therapy but the indwelling urinary catheter was changed and contact precautions were put in place. The patient cleared the organisms after 2 months, and since then has received ongoing inpatient care in the rehabilitation unit. MJA 2010; 193 (1): 59

Country No of NDM- 1 identified Remark India 70 1 st reported case originated from India Parkistan 73 Bangladesh UK 37 (5 death) Germany More than 50% with travel history to India within 1 year and almost half of them being hospitalized in India Belgium 1 A Belgium citizen, of Pakistani origin, died in June.Leg wound after receiving wound care in Parkistan France 1 Epi link to India Netherland 1 Epi link to India USA 3 All received medical care in India Canada 2 Acciation with travel history to India Australia 3 Received plastic surgery in India, travel to India HK 1 A local resident of Indian ethnicity

Most blandm-1 positive plasmids were readily transferable and prone to rearrangement, losing or (more rarely) gaining DNA on transfer. This transmissibility and plasticity implies an alarming potential to spread and diversify among bacterial populations. Control Measures: 1. Vigilant lab surveillance for early detection 2. Contact precautions for identified case 3. HH 4. Rational use of antibiotics